Related Experiment Videos
Genetic architecture of inter-individual variability in apolipoprotein, lipoprotein and lipid phenotypes
1Department of Human Genetics, University of Michigan, Ann Arbor 48109-0618.
Insights
Genetic factors significantly influence traits linked to heart disease risk, like plasma lipoproteins. The
Area of Science:
- Genetics
- Cardiovascular Disease Research
- Molecular Biology
Background:
- Coronary heart disease (CHD) risk is shaped by complex genetic and environmental interactions.
- Plasma lipoproteins, lipids, and apolipoproteins are key phenotypes linking genetic factors to CHD.
- Population studies indicate substantial genetic influence on the variability of these cardiovascular risk factors.
Purpose of the Study:
- To explore the genetic architecture of quantitative variation in plasma apolipoproteins, lipoproteins, and lipids.
- To utilize the 'measured genotype' approach for analyzing genetic contributions to cardiovascular risk phenotypes.
- To assess the utility of genetic studies for predicting CHD risk at individual and population levels.
Main Methods:
- Reviewing statistical models and sampling designs for quantitative genetic studies.
- Measuring polymorphic protein and DNA restriction site variability in relevant gene regions.
- Applying the 'measured genotype' approach to identify genetic effects on lipoprotein metabolism.
Main Results:
- Significant genetic contributions to variability in plasma apolipoproteins, lipoproteins, and lipids have been identified.
- The 'measured genotype' approach allows for the assignment of polygenic effects to specific alleles or haplotypes.
- Studies provide insights into the genetic architecture of quantitative traits related to CHD.
Conclusions:
- Understanding the genetic basis of lipoprotein metabolism is crucial for CHD prediction.
- Quantitative genetic studies offer valuable tools for dissecting complex disease etiologies.
- Future research will likely focus on integrating molecular genetic data with epidemiological findings for comprehensive risk assessment.
Abstract:
Phenotypes that predict coronary heart disease (CHD) are the consequence of interactions between many genetic and environmental factors. Quantitative measures of plasma apolipoproteins, lipoproteins and lipids are examples of phenotypes that link genetic and environmental factors to the CHD end-point. Population studies in Hawaii, Michigan and elsewhere have established that a significant fraction of variability in these phenotypes is attributable to genetic differences among individuals. Recent advances in molecular biology provide measures of the gene loci that code for the apolipoproteins, the cellular receptors for lipoprotein particles and the catalysts and cofactors in lipoprotein metabolism. By measuring polymorphic protein variability and restriction site variability in small regions of DNA known to contain genes that code for the proteins involved in these functions, it is possible to assign polygenetic effects to specific alleles or haplotypes. This 'measured genotype' approach may be used to study the genetic architecture (number of loci involved, the frequencies and effects of their alleles, and the type of loci, i.e., structural or regulatory) of quantitative variation in the plasma apolipoproteins, lipoproteins and lipids. This paper reviews statistical models, sampling designs and results of studies designed to estimate the genetic architecture of selected apolipoproteins, lipoproteins and lipids. The usefulness of these studies for answering questions about the prediction of CHD in the population, the family and the individual are discussed and the directions that human quantitative genetic studies will take in the future are considered.